Obesity, oral contraceptive use linked to rare stroke risk

15.03.20161750
Women with obesity using oral contraceptives are at greater risk for cerebral venous thrombosis than normal-weight women not using oral contraceptives, according to study results.

CHEST Guideline for Antithrombotic Therapy in VTE

14.03.20161760
The following are 11 key points about this updated guideline document from the American College of Chest Physicians on antithrombotic therapy for venous thromboembolism (VTE):

AF appears to worsen outcomes in patients with MI

11.03.20161685
In a new study, atrial fibrillation, regardless of type, was associated with increased risk for death, reinfarction and ischemic stroke in patients with MI.

Moderate drinking offers some CV benefits, but heavy drinking increases CV harm

10.03.20161682
All alcohol drinkers have an immediate higher risk for MI or stroke, but if they are moderate drinkers, that risk lessens after 24 hours, when the alcohol begins to produce some protective health benefits, according to research presented at the American Heart Association’s EPI/Lifestyle Scientific Sessions in Phoenix.

Daily chocolate consumption may improve insulin levels

09.03.20161930
Adults who consume chocolate daily are more likely to have lower insulin resistance and liver enzyme levels, according to study findings presented at the Epidemiology and Prevention/Lifestyle Scientific Sessions in Phoenix.

LMCmed Forum 2016 - A Forum of Leadership & Management in Cardiovascular Medicine - will be held on June 16-18, 2016

03.03.20161896
LMCmed Forum 2016 - A Forum of Leadership & Management in Cardiovascular Medicine will take place on June 16-18, 2016 in Vienna, Austria.

В рамках исследования EMPA REG OUTCOME® эмпаглифлозин продемонстрировал превосходство для первичной конечной сердечно-сосудистой точки и значительное снижение сердечно-сосудистой смертности у пациентов с сахарным диабетом 2-го типа

04.02.20160
Эмпаглифлозин - единственный препарат для лечения сахарного диабета 2-го типа, который продемонстрировал снижение риска возникновения сердечно-сосудистых событий и уровня смертности от сердечно-сосудистых заболеваний (ССЗ).
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.